Clinical Trial Update: Pathological Response After Neoadjuvant Treatment on NSCLC

View source ↗

Summary

This clinical trial entry reports on pathological response after neoadjuvant treatment for stage IIIA non-small cell lung cancer and notes that the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fundación GECP | Conditions: Stage IIIA Non-small Cell Lung Cancer | Status: RECRUITING